Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety and Effectiveness Study of OR3O™ Dual Mobility System in THA

NCT: NCT04325022 · ACTIVE_NOT_RECRUITING

NCT IDNCT04325022
StatusACTIVE_NOT_RECRUITING
Start Date2020-07-27
Completion2035-01-31
SponsorSmith & Nephew, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to assess the safety and effectiveness of the OR3O™ Dual Mobility System. The study will evaluate the outcome of the Total Hip Arthroplasty using the OR3O™ Dual Mobility System over a ten year period. Survivorship of THA will be assessed up to ten years.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑